Monoclonal Antibody Treatment May By Less Effective Against Omicron Variant, Drugmaker Says

The New York Times (11/30, Mueller) reports, “Regeneron said on Tuesday that its COVID-19 antibody treatment might be less effective against the Omicron variant of the coronavirus, an indication that the popular and widely beneficial monoclonal antibody d...